Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Pharmaceuticals SPDR (NY: XPH )

45.98 -0.59 (-1.27%)
Streaming Delayed Price Updated: 1:59 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 44,937
Open 46.00
Bid (Size) 45.97 (13)
Ask (Size) 46.01 (5)
Prev. Close 46.57
Today's Range 45.81 - 46.20
52wk Range 36.49 - 48.76
Shares Outstanding 35,502
Dividend Yield 1.70%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AstraZeneca Shares Fall Despite EPS Beat and Raised Guidance
AstraZeneca beat earnings-per-share (EPS) estimates and raised guidance, but shares still fell. Investors should watch for developments around the drug Enhertu. 
Via MarketBeat
Topics ETFs
Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
The Supreme Court has rejected Purdue Pharma's bankruptcy plan, exposing the Sackler family to lawsuits over their role in the opioid crisis. This decision impacts victims, state and local governments,... 
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal

Performance

YTD
+10.32%
+10.32%
1 Month
+0.68%
+0.68%
3 Month
+3.28%
+3.28%
6 Month
+14.09%
+14.09%
1 Year
+24.64%
+24.64%

More News

Read More
A Look At Pharma ETFs Post Q1 Earnings
Via Talk Markets
Topics ETFs
Organon Beats On Q1, Women's Health Leads the Charge
Via Benzinga
A Look At Pharma ETFs After Q4 Earnings
Via Talk Markets
Topics ETFs
3 Pharmaceutical ETFs That Could Be Due For A Rebound
Via Benzinga
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
Via MarketBeat
Topics Economy
Exposures Interest Rates
Pharma ETFs in Focus Post Q2 Earnings
Via Talk Markets
Topics ETFs
Pharma ETFs Gain Post Q1 Earnings
Via Talk Markets
A Look At Pharma ETFs Post Q4 Earnings
Via Talk Markets
Pharma ETFs In Focus Post Q3 Earnings
Via Talk Markets
Large Cap Biopharma- Well Positioned For Choppy Markets
Via Talk Markets
3 Pharma Stocks Yielding Over 3%
Via Talk Markets
7 Pharmaceutical Stocks That Could Make You Rich
Via InvestorPlace
The Bear Market Is Already Here – But Not For Dividend Investors
Via Talk Markets
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
Via Talk Markets
The Cost Of Saving The Economy: $1.7 Billion Per Hour Every Hour
Via Talk Markets
Topics Bonds Economy
Exposures Debt Markets Interest Rates
The 2 Best Pharma Stocks to Buy on Dips
Via Talk Markets
Exposures COVID-19
3 Top Pharma Stocks to Buy This Month
Via Talk Markets
Pharma ETFs in Focus Post Q1 Earnings
Via Talk Markets
3 Pharmaceutical ETFs That Could Be Due For A Rebound
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.